EUCTR2011-002083-25-DE
Active, not recruiting
Not Applicable
Is there a correlation between the pain relief and the A-delta- and C-fiber function after topical application of lidocaine (5%) in patients with peripheral neuropathic pain?
BG University Hospital Bergmannsheil GmbH0 sites30 target enrollmentJuly 25, 2011
DrugsVersatis
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- BG University Hospital Bergmannsheil GmbH
- Enrollment
- 30
- Status
- Active, not recruiting
- Last Updated
- 14 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Included will be patients 18 years and older either genera with:
- •\-Proven Diagnosis of painful peripheral neuropathy for at least 3 months as diagnosed as:
- •1\.Peripheral nerve lesion (i.e. pain within or adjacent to the area of nerve trauma or corresponding innervation territory or dermatome)
- •2\.Postherpetic neuralgia (Subjects with pain following herpes zoster with \> 3 months after healing of herpes zoster skin rash).
- •\- At least moderate pain intensity under the current treatment.
- •\- Unchanged and stable pain medication within the last 4 weeks.
- •\- The patients have to display some remaining sensory function at the baseline QST.
- •\- Intact skin in the area of lidocaine medicated plaster application.
- •\- Females with childbearing potential must be using adequate contraception.
- •\- Women of childbearing potential must have a negative urine ß\-human chorionic gonadotropin (ß\-HCG) pregnancy test.
Exclusion Criteria
- •Excluded will be patients with:
- •\- History of current alcohol or drug abuse.
- •\- Any scheduled surgery of painful procedure during the course of the trial.
- •\- Presence of a disease that affects the subject’s compliance.
- •\- Use of any topical anaesthetics in the area of pain within the last 6 months.
- •\- Use of capsaicin (low or high\-dose) in the area of pain within the last 6 months.
- •\- Use of TENS within the area of pain in the last 4 weeks.
- •\- Subjects who had nerve ablation by block or neurosurgical intervention for pain treatment at the affected area.
- •\- Evidence or another cause of pain within the area of pain or another severe pain condition that may interfere with the trial aims or procedures.
- •\- Severe loss of sensory function
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Prospective study of correlation between pain and anxiety after radiotherapyBone metastasisJPRN-UMIN000035023Asahi University Hospital50
Completed
Not Applicable
Comparison of Pain score and Treatment effect between Bolus infusion method and Continuous infusion method when Hypertonic saline infusion in epidural adhesiolysisDiseases of the musculo-skeletal system and connective tissueKCT0003321Seoul National University Bundang Hospital50
Recruiting
Phase 2
Comparative study between the analgesic effect of ketorolac when administrated intra-venous preoperatively versus when added to local anesthesia in squint surgeryPeribulbar block in adult patients undergoing squint surgery.IRCT20210106049952N2Research Institute of Ophthalmology90
Completed
Not Applicable
The effect of morphine in reducing paipain.Acute painIRCT2017011431931N1Iran University of Medical Sciences240
Not yet recruiting
Not Applicable
Effect of acupuncture and electro acupuncture in low back paiHealth Condition 1: M959- Acquired deformity of musculoskeletal system, unspecifiedCTRI/2023/05/052974mera Vaja